Clinical Trial Update: Imatinib and Toripalimab in Patients With Locally Advanced/Metastatic Melanoma Harbored With CKIT Mut [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating imatinib with toripalimab in CKIT-mutant locally advanced or metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Imatinib (imatinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Advanced Melanoma | Phase 2 | Status: UNKNOWN